1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Included patient characteristics (N = 40)
Patient Characteristics Value (SD) Mean age (yr) 61.5 (11.1) Age range (yr) 29–81 Male/female ratio 23:17 Pathology Primary CNS large B-cell lymphoma 40 Prior WBRT 5 Median follow-up (yr)a 3.01 Total baseline MR imaging 33 Total baseline CT 7 Total follow-up MR imaging 254 Total follow-up CT 10 Mean number of MR images per patient 7.60 (3.49) Mean number of lesions on baseline MR image 2.33 (1.14) Disease location Superficial 16 Deep 15 Mixed 9 Particular disease distribution Midline crossing lesion 10 Multifocal, bilateral lesions 16 Induction responsea 22 Relapse after inductiona 12
Note:—WBRT indicates whole brain radiotherapy; SD, standard deviation.
↵a One patient was lost to follow-up, and 5 stopped their treatment for palliative care and were not included in this analysis.